Scinovex
article Open AccessTop 1% cited

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

The Journal of Infectious Diseases · 2009 · Vol. 201(1) · pp. 32–41
Tamara PilishviliCatherine LexauMonica M. FarleyJames L. HadlerLee H. HarrisonNancy M. BennettArthur ReingoldAnn ThomasWilliam SchaffnerAllen S. CraigPhilip J SmithBernard BeallCynthia G. WhitneyMatthew R. Moore

Abstract

Dramatic reductions in IPD after PCV7 introduction in the United States remain evident 7 years later. IPD rates caused by serotype 19A and other non-PCV7 types have increased but remain low relative to decreases in PCV7-type IPD.

Pneumonia and Respiratory InfectionsRespiratory viral infections researchPneumocystis jirovecii pneumonia detection and treatmentPneumococcal diseasePneumococcal conjugate vaccinePneumococcal infectionsStreptococcus pneumoniaeConjugateMedicineVirologyConjugate vaccineImmunologyImmunogenicity

MeSH terms

Heptavalent Pneumococcal Conjugate VaccineAdolescentAdultAgedChildChild, PreschoolHumansMiddle AgedPneumococcal InfectionsPopulation SurveillanceSerotypingStreptococcus pneumoniaeUnited StatesIncidenceAge Distribution
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine · Scinovex